DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Mastellos DC, Pires da Silva BGP, Fonseca BAL. et al.
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy.
Clin Immunol 2020;
220: 108598
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.